| Item Type | Name |
|
Concept
|
Fatty Acids, Volatile
|
|
Concept
|
Aminosalicylic Acids
|
|
Concept
|
Pentanoic Acids
|
|
Concept
|
Polymethacrylic Acids
|
|
Academic Article
|
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
|
|
Academic Article
|
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.
|
|
Academic Article
|
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
|
|
Academic Article
|
Update on medical management of inflammatory bowel disease: ulcerative colitis.
|
|
Academic Article
|
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
|
|
Academic Article
|
Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.
|
|
Academic Article
|
Treatment of inflammatory bowel disease: safety and tolerability issues.
|
|
Academic Article
|
Review article: the long-term management of ulcerative colitis.
|
|
Academic Article
|
Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
|
|
Academic Article
|
Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.
|
|
Academic Article
|
Unemployment and disability in patients with moderately to severely active Crohn's disease.
|
|
Academic Article
|
Review article: aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
|
|
Academic Article
|
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
|
|
Academic Article
|
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
|
|
Academic Article
|
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
|
|
Academic Article
|
Controversies with aminosalicylates in inflammatory bowel disease.
|
|
Academic Article
|
Aminosalicylates: old and new.
|
|
Academic Article
|
Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials.
|
|
Academic Article
|
Treatment of inflammatory bowel disease: a review of medical therapy.
|
|
Academic Article
|
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
|
|
Academic Article
|
5-ASA enema therapy.
|
|
Academic Article
|
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
|
|
Academic Article
|
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
|
|
Academic Article
|
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
|
|
Academic Article
|
Inflammatory bowel disease.
|
|
Academic Article
|
Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acid.
|
|
Academic Article
|
Mesalamine capsules enhance the quality of life for patients with ulcerative colitis.
|
|
Academic Article
|
Medical therapy for ulcerative colitis 2004.
|
|
Academic Article
|
The role of mesalazine in Crohn's disease.
|
|
Academic Article
|
Medical therapy of ulcerative colitis.
|
|
Academic Article
|
Aminosalicylates for induction of remission or response in Crohn's disease.
|